ANDA 206747, held by Cadila Pharmaceuticals. Voriconazole.
As of Nov 21, 2026, ANDA 206747 (Voriconazole), held by Cadila Pharmaceuticals, was first approved by FDA on May 24, 2016, with 13 approved supplements and 0 published complete response letters.
Voriconazole is an azole antifungal indicated for the treatment of adults and pediatric patients aged 2 years of age and older with:
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 24, 2016 | Original application | Approved | None posted |
| Voriconazole50MG · tablet;oral | Voriconazole | Rx |
| Voriconazole200MG · tablet;oral | Voriconazole | Rx |
| Oct 23, 2025 | Supplement 17Labeling · Standard review | Approved | None posted |
| Aug 8, 2023 | Supplement 14Labeling · Standard review | Approved | None posted |
| Aug 8, 2023 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jun 13, 2022 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jun 13, 2022 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jun 13, 2022 | Supplement 12Labeling · Standard review | Approved | None posted |
| Mar 15, 2021 | Supplement 5Labeling · Standard review | Approved | None posted |
| Mar 15, 2021 | Supplement 7Labeling · Standard review | Approved | None posted |
| Mar 15, 2021 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jul 9, 2019 | Supplement 1Labeling · Standard review | Approved | None posted |
| Jul 9, 2019 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jul 9, 2019 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jul 9, 2019 | Supplement 4Labeling · Standard review | Approved | None posted |
| May 24, 2016 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters